Efficacy and Safety of Triple Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Patients With Cystic Fibrosis: A Meta-Analysis of Randomized Controlled Trials

Background: Cystic fibrosis is a rare, recessive, progressive genetic disease caused by dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Small molecules have recently been developed to treat the molecular consequences of CFTR mutations and restore CFTR protein f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yizi, Ma, Bin, Li, Wenya, Li, Peiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964016/
https://www.ncbi.nlm.nih.gov/pubmed/35359862
http://dx.doi.org/10.3389/fphar.2022.863280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964016/
https://www.ncbi.nlm.nih.gov/pubmed/35359862
http://dx.doi.org/10.3389/fphar.2022.863280

Ejemplares similares